Strategic and Scientific Advisory Board 

Martin Freed, MD

Dr. Martin Freed brings more than 25 years of strategic development and operational expertise from across the biopharmaceutical and life sciences industries.

As a seasoned drug development executive and life sciences entrepreneur, his experience spans from Phase 1 drug development through to post-registration clinical development and medical affairs programming across numerous therapeutic areas.

Dr. Freed has held senior leadership positions with various biopharmaceutical companies, most recently as Co-Founder and Chief Medical Officer of Civitas Therapeutics, Inc., which was acquired by Acorda Therapeutics Inc. in 2014. Prior to Civitas, he held leadership positions at Adnexus Therapeutics, Inc., Vitae Pharmaceuticals, Inc. and SmithKline Beecham Pharmaceuticals/GlaxoSmithKline. Dr. Freed has been published in more than 40 peer reviewed manuscripts, four book chapters and more than 90 abstracts related to an array of drug development and translational medicine programs. Currently, Dr. Freed also holds Board positions with Dicerna Pharmaceuticals, Inc. and Sojournix, Inc.

Dr. Freed performed his internal medicine residency at Temple University Hospital and nephrology fellowship at Yale-New Haven Hospital.

Other Team Members

Sylvie Breton

Professor Sylvie Breton, PhD, is a Professor of Medicine at Harvard Medical School, and directs the Breton Laboratory within the Program in Membrane Biology / Center for Systems Biology in the Nephrology Division at the Massachusetts General Hospital.

View bio

Glenn Batchelder

Mr. Glenn Batchelder previously was Co-Founder and CEO of Civitas Therapeutics, a development stage pulmonary delivery therapeutic company based on the ARCUS technology platform that was sold to Acorda Therapeutics.

View bio

John Randle

Dr. John C.R. Randle, PhD, brings over 30 years of practical, hands-on experience to the business of drug candidate selection and development.

View bio

Andrea Franz

Ms. Franz is a financial executive with over 25 years of experience in small to mid-size biotechnology companies.

View bio

Dennis Ausiello, MD

Dennis A. Ausiello, MD, is the Director of the Center for Assessment Technology and Continuous Health (CATCH) at MGH; Jackson Distinguished Professor of Clinical Medicine, Emeritus at Harvard Medical School; and the Physician-in-Chief, Emeritus of the Department of Medicine at MGH.

View bio

Dennis Brown, PhD

Prof. Dennis Brown is an internationally recognized expert on renal physiology and kidney function at the Massachusetts General Hospital (Nephrology Division) and Harvard Medical School.

View bio

Todd Rosengart, MD

Dr. Todd Rosengart is a nationally recognized cardiothoracic surgeon, a National Institutes of Health (NIH)-supported scientist, and an extensively published investigator.

View bio

Sushrat Waikar, MD, Mph

Sushrut Waikar, MD, MPH, Clinical Advisor, is Associate Professor of Medicine, BWH/HMS. He is Director of Translational Research and Ambulatory Services, BWH and is an expert in acute and chronic kidney disease.

View bio

Winfred W. Williams, MD

Winfred W. Williams, MD, Medical Advisor, is Nephrologist and Associate Chief of the Division of Nephrology at MGH/HMS. He is Director of the Program in Interventional Nephrology for the Transplantation Unit at MGH.

View bio